INDBInternet News Database 2.5 Updated 1 min ago · 306 sources Show or hide images Light or dark

Results for “Wegovy Science Daily”

Science
1 source

Who is covering this

Google NewsCenter
Truth score 41
Centre 100%100%
Google NewsCenter

Should you take GLP-1s during pregnancy? What some doctors say.

Should you take GLP-1s during pregnancy? What some doctors say. The Washington Post Weight-Loss Drug Quietly Cut Oxygen to the Fetus in Pregnant Sheep StudyFinds Study of 750,000 pregnancies reveals a surprising twist about Ozempic and...

Lean: Center Fact-focusedFactuality: HighCountry: United StatesFunding: Corporate
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States100%
Media ownership
Google News100%
Avg reliability75
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 41 (Limited corroboration) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 75 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Like
Health
1 source

Who is covering this

MedpagetodayCenter
Truth score 38
Centre 100%100%
MedpagetodayCenter

Wegovy Reduces BMI in Kids With Obesity as Young as 6

(MedPage Today) -- NATIONAL HARBOR, Md. -- Young children ages 6 to 11 years with obesity lost significant weight with the GLP-1 medication semaglutide (Wegovy), according to results from the phase III STEP Young trial. At week 68, mean body...

Lean: Center Fact-focusedFactuality: Mostly factualCountry: United StatesFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States100%
Media ownership
Independent100%
Avg reliability65
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 38 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: 0Sensationalism: 0 Amplification: 0

How we score

Like
Health
2 sources

Who is covering this

ReutersCenterYahoo NewsCenter
Truth score 531
Centre 100%100%
ReutersCenter

Novo Nordisk's Wegovy pill beats forecasts as it battles Lilly

Novo Nordisk's Wegovy pill beats forecasts as it battles Lilly Reuters

Lean: Center Fact-focusedFactuality: Very highCountry: United KingdomFunding: CorporateOwner: Thomson Reuters
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United Kingdom50%
United States50%
Media ownership
Thomson Reuters50%
Apollo Global Management50%
Avg reliability81
Low-credibility share0%
Fact / opinion2/0
State media0%
More analysis
Truth score: 53 (Limited corroboration) Propaganda risk: 0 Trending: Low Sources: 2 Reliability: 81 Bias severity: 0 Risk: 0Sentiment: 0Sensationalism: 0 Amplification: 0

How we score

Like
Health
1 source

Who is covering this

CNBCCenter
Truth score 43
Centre 100%100%
CNBCCenter

Novo says Wegovy injection lowers BMI and obesity rates in children in trial

Wegovy is already approved to treat obesity in children ages 12 and older, but there are currently no approved medications for those under 12.

Lean: Center Fact-focusedFactuality: HighCountry: United StatesFunding: Corporate
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States100%
Media ownership
CNBC100%
Avg reliability80
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 43 (Limited corroboration) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 80 Bias severity: 0 Risk: 0Sentiment: 100Sensationalism: 0 Amplification: 0

How we score

Like
Health
1 source

Who is covering this

Daily MailCenter
Truth score 37
Centre 100%100%
Daily MailCenter

I started using the Wegovy pill to save money and I gained 6lb within weeks. So many are piling on the pounds thanks to these mistakes... this is what you need to know - and how to supercharge your weight loss

For Allie Hudson, the fat jab Mounjaro was supposed to be the final stop on a long journey to a healthy weight.

Lean: Center Fact-focusedFactuality: Mostly factualCountry: United KingdomFunding: CorporateOwner: DMGT
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United Kingdom100%
Media ownership
DMGT100%
Avg reliability63
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 37 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 63 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Like
1 source

Who is covering this

CNBCCenter
Truth score 43
Centre 100%100%
CNBCCenter

Novo raises full-year outlook as Wegovy pill sales impress

Novo posted quarterly earnings ahead of expectations early Wednesday as sales of its Wegovy pill blew past estimates

Lean: Center Fact-focusedFactuality: HighCountry: United StatesFunding: Corporate
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States100%
Media ownership
CNBC100%
Avg reliability80
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 43 (Limited corroboration) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 80 Bias severity: 0 Risk: 0Sentiment: 0Sensationalism: 0 Amplification: 0

How we score

Like
Left 100%100%
USA TODAYLeans left

DJ Khaled reveals 90-pound weight loss with Wegovy: 'I needed help'

DJ Khaled reveals 90-pound weight loss with Wegovy: 'I needed help' USA Today

Lean: Leans left Fact-focusedFactuality: HighCountry: United StatesFunding: CorporateOwner: Gannett
  • Eonline DJ Khaled Details Journey to 75-Pound Weight Loss Transformation

    These days, DJ Khaled isn’t going for another one—especially when it comes to food. After the “I’m the One” rapper sparked major attention for his 75-pound weight loss, he confirmed his...

    Lean: No political lean Fact-focusedCountry: CanadaFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
Canada50%
United States50%
Media ownership
Independent50%
Gannett50%
Avg reliability78
Low-credibility share0%
Fact / opinion2/0
State media0%
More analysis
Truth score: 52 (Limited corroboration) Propaganda risk: 0 Trending: Low Sources: 2 Reliability: 78 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Like
Culture
1 source

Who is covering this

QuartzLeans left
Truth score 40
Left 100%100%
QuartzLeans left

11 GLP-1 side effects to know before taking Ozempic, Wegovy, or Zepbound

From nausea to bone loss, GLP-1 drugs such as Ozempic, Wegovy, and Zepbound can cause side effects. Here are 11 to know, plus tips to manage them.

Lean: Leans left Fact-focusedFactuality: HighCountry: United StatesFunding: CorporateOwner: G/O Media
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States100%
Media ownership
G/O Media100%
Avg reliability72
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 40 (Limited corroboration) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 72 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Like
Health
2 sources

Who is covering this

ReutersCenterAmherst BeeNot rated
Truth score 57
Centre 100%100%
ReutersCenter

Lilly says its obesity drugs helped patients lose weight in clinical trials

Lilly says its obesity drugs helped patients lose weight in clinical trials Reuters

Lean: Center Fact-focusedFactuality: Very highCountry: United KingdomFunding: CorporateOwner: Thomson Reuters
+ 1 · Full coverage
Coverage breakdown
Funding
Corporate50%
Not recorded50%
Countries
United Kingdom50%
United States50%
Media ownership
Thomson Reuters50%
Amherst Bee50%
Avg reliability92
Low-credibility share0%
Fact / opinion3/0
State media0%
More analysis
Truth score: 57 (Limited corroboration) Propaganda risk: 0 Trending: Low Sources: 2 Reliability: 92 Bias severity: 0 Risk: 0Sentiment: 0Sensationalism: 0 Amplification: 0

How we score

Like
Left 46%46%Centre 42%42%Right 12%12%
BBC NewsCenter

Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness

The US Food and Drug Administration says Ozempic, Wegovy, and other weight-loss drugs must have labels about the condition, known as NAION. Companies making popular weight loss drugs, including Ozempic and Wegovy, will be required to...

Lean: Center Fact-focusedFactuality: Very highCountry: United KingdomFunding: Public broadcasterOwner: BBC (UK Government)
+ 37 · Full coverage
Coverage breakdown
Funding
Corporate62%
Not recorded17%
Public broadcaster7%
Private7%
Nonprofit3%
Countries
United States76%
India14%
United Kingdom10%
Media ownership
Independent19%
Comcast12%
G/O Media12%
WSNS-TV6%
Google News6%
Avg reliability74
Low-credibility share4%
Fact / opinion42/0
State media0%
More analysis
Truth score: 91 (Strongly corroborated) Propaganda risk: 0 Trending: Low Sources: 29 Reliability: 74 Bias severity: 57 Risk: 4Sentiment: -95Sensationalism: 0 Amplification: 0

How we score

Like
Left 50%50%Centre 50%50%
ABC News (Australia)Center

TGA clears weight loss tablets for use in Australia

A daily Wegovy tablet has been cleared for use in Australia, with the weight loss tablet expected to hit shelves before Christmas. Wegovy’s GLP-1 weight loss tablet has been approved in Australia for the first time, expected to lead to...

Lean: Center Fact-focusedFactuality: Very highCountry: AustraliaFunding: Public broadcasterOwner: Australian Government
  • NBC News New Weight Loss Drug Could Also Treat Knee Arthritis: Study

    A recent poll found about 1-in-8 American adults say they’re currently taking GLP-1 weight loss drugs and now a study in The England Journal of Medicine finds that one drug, retatrutide, currently in trials, could...

    Lean: Leans left VideoFactuality: HighCountry: United StatesFunding: CorporateOwner: Comcast
  • Medscape Keeping the Weight Off After Stopping a GLP-1

    Weight regain is common after GLP-1 discontinuation. Experts discuss strategies that may help patients maintain their weight loss.

    Lean: Center Fact-focusedFactuality: Mostly factualCountry: United StatesFunding: CorporateOwner: Independent
  • The Sydney Morning Herald First GLP-1 weight loss pill in Australia to hit market by end of the year

    Wegovy’s GLP-1 weight loss tablet has been approved in Australia for the first time, expected to lead to a surge in demand for the sought-after peptide which could hit the market by the end of this year.

    Lean: Leans left Fact-focusedFactuality: HighCountry: AustraliaFunding: CorporateOwner: Nine Entertainment
+ 3 · Full coverage
Coverage breakdown
Funding
Corporate75%
Public broadcaster25%
Countries
Australia50%
United States50%
Media ownership
Australian Government25%
Nine Entertainment25%
Independent25%
Comcast25%
Avg reliability77
Low-credibility share0%
Fact / opinion7/0
State media0%
More analysis
Truth score: 67 (Corroborated) Propaganda risk: 0 Trending: Low Sources: 4 Reliability: 77 Bias severity: 0 Risk: 0Sentiment: -52Sensationalism: 1 Amplification: 0

How we score

Like